Articles > The Many Facets of SDF-1alpha CXCR4 Agonists and Antagonists on Hematopoietic Progenitor Cells

The Many Facets of SDF-1alpha CXCR4 Agonists and Antagonists on Hematopoietic Progenitor Cells

  1. K. Imai, M. Kobayashi, and J. Wang, et al., “Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenitor cells to bone marrow,” British Journal of Haematology, vol. 106, no. 4, pp. 905–911, 1999.
  2. A. Dar, P. Goichberg, and V. Shinder, et al., “Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells,” Nature Immunology, vol. 6, no. 10, pp. 1038–1046, 2005.
  3. M. Shirozu, T. Nakano, and J. Inazawa, et al., “Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene,” Genomics, vol. 28, no. 3, pp. 495–500, 1995.
  4. T. Shioda, H. Kato, and Y. Ohnishi, et al., “Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 11, pp. 6331–6336, 1998.
  5. S. M. de La Luz, F. Yang, and M. Narazaki, et al., “Differential processing of stromal-derived factor-1α and stromal-derived factor-1β explains functional diversity,” Blood, vol. 103, no. 7, pp. 2452–2459, 2004.
  6. I. Petit, P. Goichberg, and A. Spiegel, et al., “Atypical PKC-ζ regulates SDF-1-mediated migration and development of human CD34+ progenitor cells,” Journal of Clinical Investigation, vol. 115, no. 1, pp. 168–176, 2005.
  7. R. Möhle, F. Bautz, S. Rafii, M. A. S. Moore, W. Brugger, and L. Kanz, “The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1,” Blood, vol. 91, no. 12, pp. 4523–4530, 1998.
  8. C. H. Kim and H. E. Broxmeyer, “In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment,” Blood, vol. 91, no. 1, pp. 100–110, 1998.
  9. J. P. Chute, “Stem cell homing,” Current Opinion in Hematology, vol. 13, no. 6, pp. 399–406, 2006.
  10. S. Fruehauf, K. Srbic, R. Seggewiss, J. Topaly, and A. D. Ho, “Functional characterization of podia formation in normal and malignant hematopoietic cells,” Journal of Leukocyte Biology, vol. 71, no. 3, pp. 425–432, 2002.
  11. S. Tavor, I. Petit, and S. Porozov, et al., “Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice,” Blood, vol. 106, no. 6, pp. 2120–2127, 2005.
  12. J.-J. Lataillade, D. Clay, and C. Dupuy, et al., “Chemokine SDF-1 enhances circulating CD34+ cell proliferation in synergy with cytokines: possible role in progenitor survival,” Blood, vol. 95, no. 3, pp. 756–768, 2000.
  13. J.-J. Lataillade, D. Clay, and P. Bourin, et al., “Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G0/G1 transition in CD34+ cells: evidence for an autocrine/paracrine mechanism,” Blood, vol. 99, no. 4, pp. 1117–1129, 2002.
  14. Y. Lee, A. Gotoh, and H.-J. Kwon, et al., “Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines,” Blood, vol. 99, no. 12, pp. 4307–4317, 2002.
  15. J. Kijowski, M. Baj-Krzyworzeka, and M. Majka, et al., “The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells,” Stem Cells, vol. 19, no. 5, pp. 453–466, 2001.
  16. H. E. Broxmeyer, L. Kohli, and C. H. Kim, et al., “Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Gαi proteins and enhances engraftment of competitive, repopulating stem cells,” Journal of Leukocyte Biology, vol. 73, no. 5, pp. 630–638, 2003.
  17. K. Hattori, B. Heissig, and K. Tashiro, et al., “Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells,” Blood, vol. 97, no. 11, pp. 3354–3360, 2001.
  18. C. C. Bleul, M. Farzan, and H. Choe, et al., “The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry,” Nature, vol. 382, no. 6594, pp. 829–833, 1996.
  19. J.-I. Yamaguchi, K. F. Kusano, and O. Masuo, et al., “Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization,” Circulation, vol. 107, no. 9, pp. 1322–1328, 2003.
  20. J.-F. Wang, I.-W. Park, and J. E. Groopman, “Stromal cell-derived factor-1α stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C,” Blood, vol. 95, no. 8, pp. 2505–2513, 2000.
  21. P. Goichberg, A. Kalinkovich, and N. Borodovsky, et al., “cAMP-induced PKC-ζ activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors,” Blood, vol. 107, no. 3, pp. 870–879, 2006.
  22. C. Tudan, G. E. Willick, and S. Chahal, et al., “C-terminal cyclization of an SDF-1 small peptide analogue dramatically increases receptor affinity and activation of the CXCR4 receptor,” Journal of Medicinal Chemistry, vol. 45, no. 10, pp. 2024–2031, 2002.
  23. S. Villalba, O. Salvucci, and Y. Aoki, et al., “Serum inactivation contributes to the failure of stromal-derived factor-1 to block HIV-1 infection in vivo,” Journal of Leukocyte Biology, vol. 74, no. 5, pp. 880–888, 2003.
  24. K. Li, C. K. Y. Chuen, and S. M. Lee, et al., “Small peptide analogue of SDF-1α supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice,” Stem Cells, vol. 24, no. 1, pp. 55–64, 2006.
  25. R. Zhong, P. Law, D. Wong, A. Merzouk, H. Salari, and E. D. Ball, “Small peptide analogs to stromal derived factor-1 enhance chemotactic migration of human and mouse hematopoietic cells,” Experimental Hematology, vol. 32, no. 5, pp. 470–475, 2004.
  26. E. de Clercq, “Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100,” Mini-Reviews in Medicinal Chemistry, vol. 5, no. 9, pp. 805–824, 2005.
  27. H. E. Broxmeyer, C. M. Orschell, and D. W. Clapp, et al., “Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist,” Journal of Experimental Medicine, vol. 201, no. 8, pp. 1307–1318, 2005.
  28. S. Fruehauf, T. Seeger, and P. Maier, et al., “The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics,” Experimental Hematology, vol. 34, no. 8, pp. 1052–1059, 2006.
  29. W. Wagner, A. Ansorge, and U. Wirkner, et al., “Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis,” Blood, vol. 104, no. 3, pp. 675–686, 2004.
  30. S. Huang, P. Law, K. Francis, B. O. Palsson, and A. D. Ho, “Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules,” Blood, vol. 94, no. 8, pp. 2595–2604, 1999.
  31. M. Reyes, T. Lund, T. Lenvik, D. Aguiar, L. Koodie, and C. M. Verfaillie, “Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells,” Blood, vol. 98, no. 9, pp. 2615–2625, 2001.
  32. W. Wagner, F. Wein, and A. Seckinger, et al., “Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood,” Experimental Hematology, vol. 33, no. 11, pp. 1402–1416, 2005.
  33. W. Wagner, R. E. Feldmann Jr., and A. Seckinger, et al., “The heterogeneity of human mesenchymal stem cell preparations – Evidence from simultaneous analysis of proteomes and transcriptomes,” Experimental Hematology, vol. 34, no. 4, pp. 536–548, 2006.
  34. W. Wagner, F. Wein, and C. Roderburg, et al., “Adhesion of hematopoietic progenitor cells to human mesenchymal stromal cells as a model for cell-cell interaction,” Experimental Hematology, vol. 35, no. 2, pp. 314–325, 2007.
  35. W. Holloway, A. R. Martinez, D. J. Oh, K. Francis, R. Ramakrishna, and B. O. Palsson, “Key adhesion molecules are present on long podia extended by hematopoietic cells,” Cytometry, vol. 37, no. 3, pp. 171–177, 1999.
  36. D. J. Oh, A. R. Martinez, G. M. Lee, K. Francis, and B. O. Palsson, “Intercellular adhesion can be visualized using fluorescently labeled fibrosarcoma HT1080 cells cocultured with hematopoietic cell lines or CD34+ enriched human mobilized peripheral blood cells,” Cytometry, vol. 40, no. 2, pp. 119–125, 2000.
  37. A. E. Frimberger, C. I. McAuliffe, and K. A. Werme, et al., “The fleet feet of haematopoietic stem cells: rapid motility, interaction and proteopodia,” British Journal of Haematology, vol. 112, no. 3, pp. 644–654, 2001.
  38. W. Wagner, R. Saffrich, and U. Wirkner, et al., “Hematopoietic progenitor cells and cellular microenvironment: behavioral and molecular changes upon interaction,” Stem Cells, vol. 23, no. 8, pp. 1180–1191, 2005.
  39. J. D. van Buul, C. Voermans, J. van Gelderen, E. C. Anthony, C. E. van der Schoot, and P. L. Hordijk, “Leukocyte-endothelium interaction promotes SDF-1-dependent polarization of CXCR4,” Journal of Biological Chemistry, vol. 278, no. 32, pp. 30302–30310, 2003.
  40. M. J. Orsini, J.-L. Parent, S. J. Mundell, J. L. Benovic, and A. Marchese, “Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization,” Journal of Biological Chemistry, vol. 274, no. 43, pp. 31076–31086, 1999.
  41. A. Sachpatzidis, B. K. Benton, and J. P. Manfredi, et al., “Identification of allosteric peptide agonists of CXCR4,” Journal of Biological Chemistry, vol. 278, no. 2, pp. 896–907, 2003.
  42. A. Aiuti, I. J. Webb, C. Bleul, T. Springer, and J. C. Gutierrez-Ramos, “The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood,” Journal of Experimental Medicine, vol. 185, no. 1, pp. 111–120, 1997.
  43. D. E. Wright, E. P. Bowman, A. J. Wagers, E. C. Butcher, and I. L. Weissman, “Hematopoietic stem cells are uniquely selective in their migratory response to chemokines,” Journal of Experimental Medicine, vol. 195, no. 9, pp. 1145–1154, 2002.
  44. A. Avigdor, P. Goichberg, and S. Shivtiel, et al., “CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow,” Blood, vol. 103, no. 8, pp. 2981–2989, 2004.
  45. A. Larochelle, A. Krouse, and M. Metzger, et al., “AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates,” Blood, vol. 107, no. 9, pp. 3772–3778, 2006.
  46. S. Basu and H. E. Broxmeyer, “Transforming growth factor-β1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12,” Blood, vol. 106, no. 2, pp. 485–493, 2005.
  47. N. Wright, T. L. de Lera, and C. García-Moruja, et al., “Transforming growth factor-β1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion,” Blood, vol. 102, no. 6, pp. 1978–1984, 2003.
  48. R. F. Wynn, C. A. Hart, and C. Corradi-Perini, et al., “A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow,” Blood, vol. 104, no. 9, pp. 2643–2645, 2004.
  49. S. Bhakta, P. Hong, and O. Koc, “The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation,” Cardiovascular Revascularization Medicine, vol. 7, no. 1, pp. 19–24, 2006.
  50. B.-R. Son, L. A. Marquez-Curtis, and M. Kucia, et al., “Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases,” Stem Cells, vol. 24, no. 5, pp. 1254–1264, 2006.
  51. S. Hatse, K. Princen, and K. Vermeire, et al., “Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry,” FEBS Letters, vol. 546, no. 2-3, pp. 300–306, 2003.
  52. S. P. Forde, T. B. Jorgensen, and S. E. Newey, et al., “Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells,” Blood, vol. 109, no. 5, pp. 1825–1833, 2007.
  53. D. A. Sipkins, X. Wei, and J. W. Wu, et al., “In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment,” Nature, vol. 435, no. 7044, pp. 969–973, 2005.
  54. J. A. Burger and T. J. Kipps, “CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment,” Blood, vol. 107, no. 5, pp. 1761–1767, 2006.

You will also like...